Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 2Urogenital Neoplasms 1Gastric Adenocarcinoma 1Erectile Dysfunction 1

Interventions

trametinib 1sotorasib 1selpercatinib 1pembrolizumab 1osimertinib 1lorlatinib 1dabrafenib 1cemiplimab 1brigatinib 1alectinib 1Tadalafil 1Surveys and Questionnaires 1Pemetrexed 1Paclitaxel 1Nivolumab 1High-Intensity Focused Ultrasound Ablation 1Educational Status 1Carboplatin 14-Aminopyridine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Erectile Dysfunction × Tadalafil × Clear all
NCT05558007 2024-10-22

Safety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized Patients

Biozeus Biopharmaceutical S.A.

Phase 2 Recruiting
72 enrolled
Genitourinary

Erectile Dysfunction, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡